Thorlabs Extends VEGA Swept Source OCT Offering
January 7, 2019
Newton, NJ – Thorlabs announced today that it has added to its well-established VEGA™ OCT line by releasing complete imaging systems, VEG210C1 and VEG220C1. Based on Thorlabs’ MEMS-VCSEL swept-wavelength laser source technology, these new systems are available in both 100 kHz (VEG210) and 200 kHz (VEG220) variants. Both offer the same low roll-off and high sensitivity [...]
January 7, 2019
Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250 Billion Global Biopharmaceuticals Market SOUTH EASTON, MA / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of enabling high [...]
January 7, 2019
SAN FRANCISCO--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its Application Programming Interface (Twist API or TAPI) available for all [...]
Phenomenex Opens Office for Direct Sales and Support in Taiwan
January 7, 2019
Torrance, Calif. – Phenomenex, Inc., a global leader in the research and manufacturer of advanced technologies for the separation sciences, announced today that it has opened an office to directly serve customers in Taiwan. Phenomenex is a leading player in proprietary chromatography consumables, serving the liquid and gas chromatography market. Over the past 36 years [...]
PHIL PALMER JOINS PUROLITE PRODUCTION TEAM AS WAREHOUSE AND MATERIALS MANAGER
January 7, 2019
Philadelphia, PA - Purolite is proud to announce that Phil Palmer has joined the G-street production plant team as Warehouse and Materials Manager. Phil comes to Purolite with 20 years of Warehouse management experience, having worked in both operations management and chemical manufacturing. Phil will report to Warner Jarnagin, Plant Director. “I saw an opportunity to [...]
January 7, 2019
Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology This collaboration reflects an initial phase of a multi study plan in the field of ophthalmology Further step to establish AYOXXA LUNARISTM system as the standard for [...]
January 7, 2019
SAN FRANCISCO -- Today Color announced an initiative to help build the foundation for the first mainstream application of whole genome sequencing in clinical care, through the use of polygenic risk scores. Polygenic risk scoring can help clinicians identify populations who are at risk for diseases such as cancer and heart disease in order to optimize prevention [...]
January 6, 2019
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal [...]
January 6, 2019
–Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – Paragon Genomics, Inc., a [...]
PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics
January 4, 2019
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis ST. LOUIS--PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics [...]
